Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Current Leases (2019 - 2024)

Serina Therapeutics (SER) has disclosed Current Leases for 4 consecutive years, with $11000.0 as the latest value for Q2 2024.

  • Quarterly Current Leases changed N/A to $11000.0 in Q2 2024 from the year-ago period, while the trailing twelve-month figure was $11000.0 through Jun 2024, changed N/A year-over-year, with the annual reading at $36000.0 for FY2023, N/A changed from the prior year.
  • Current Leases hit $11000.0 in Q2 2024 for Serina Therapeutics, down from $24000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $325000.0 in Q1 2020 to a low of $11000.0 in Q2 2024.
  • Historically, Current Leases has averaged $120500.0 across 3 years, with a median of $72500.0 in 2020.
  • Biggest YoY gain for Current Leases was 46.44% in 2020; the steepest drop was 73.86% in 2020.
  • Year by year, Current Leases stood at $109000.0 in 2020, then crashed by 66.97% to $36000.0 in 2023, then tumbled by 69.44% to $11000.0 in 2024.
  • Business Quant data shows Current Leases for SER at $11000.0 in Q2 2024, $24000.0 in Q1 2024, and $36000.0 in Q4 2023.